Externally Validated Machine Learning Models for 30-/90-/180-Day Unplanned Readmission After Head and Neck Cancer Hospitalizations in the United States Between January and June 2025, diagnostic ...
The prevalence of objectively measurable disease in phase III trials of metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the 2016 Genitourinary Cancers ...
Google AI outperforms general pathologists at validating Gleason grading of prostate cancer biopsies
A team of researchers from Google Health, working with others from institutions across the U.S. and Canada has found that a Google AI system was able to outperform general pathologists when validating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results